Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifabutin for S. aureus eradication in HIV
NCT00869518Phase 2Terminated
- Sponsor
- University of California, San Francisco
- Start
- Jul 2009
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rifabutin in Staphylococcus aureus colonization, sponsored by University of California, San Francisco. Started Jul 2009; status: terminated.
02
Drugs
rifabutin
03
Conditions
Staphylococcus aureus colonization
Beyond the preview
Go deeper on NCT00869518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00869518.